We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-24.36%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$4.79B
AUM Growth
-$1.68B
Cap. Flow
+$133M
Cap. Flow %
2.78%
Top 10 Hldgs %
74.69%
Holding
80
New
4
Increased
7
Reduced
9
Closed
16

Top Buys

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$280M
2
JD icon
JD.com
JD
+$249M
3
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$145M
4
VIPS icon
Vipshop
VIPS
+$116M
5
YMM icon
Full Truck Alliance
YMM
+$77.6M

Top Sells

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$192M
2
ONON icon
On Holding
ONON
+$178M
3
ERAS icon
Erasca
ERAS
+$73.6M
4
LI icon
Li Auto
LI
+$69.2M
5
AMG icon
Affiliated Managers Group
AMG
+$55.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.67%
2 Consumer Discretionary 35.71%
3 Technology 14.57%
4 Communication Services 5.27%
5 Consumer Staples 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YSG
26
Yatsen Holding
YSG
$240M
$27.8M 0.58%
8,090,343
– –
TIL icon
27
Instil Bio
TIL
$48.9M
$25.6M 0.54%
119,273
– –
AKRO
28
DELISTED
Akero Therapeutics
AKRO
$19.3M 0.4%
1,359,152
– –
SNOW icon
29
Snowflake
SNOW
$114B
$14.4M 0.3%
63,000
– –
ACMR icon
30
ACM Research
ACMR
$4.45B
$13.9M 0.29%
670,755
– –
SOHU
31
Sohu.com
SOHU
$359M
$13.5M 0.28%
802,034
– –
MLCO icon
32
Melco Resorts & Entertainment
MLCO
$1.76B
$13M 0.27%
1,698,877
– –
FMTX
33
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$10.2M 0.21%
1,100,000
– –
HTHT icon
34
Huazhu Hotels Group
HTHT
$13.3B
$10M 0.21%
303,200
-275,702
-48% -$10.2M
DYN icon
35
Dyne Therapeutics
DYN
$3.34B
$9.64M 0.2%
1,000,000
– –
IPSC icon
36
Century Therapeutics
IPSC
$359M
$7.73M 0.16%
614,095
– –
ADCT icon
37
ADC Therapeutics
ADCT
$139M
$7.34M 0.15%
500,000
– –
ALLO icon
38
Allogene Therapeutics
ALLO
$594M
$7.29M 0.15%
800,000
– –
TRML
39
DELISTED
Tourmaline Bio
TRML
$6.88M 0.14%
69,880
-6,309
-8% -$590K
TNGX icon
40
Tango Therapeutics
TNGX
$4.03B
$6.69M 0.14%
882,088
-2,991,894
-77% -$25.9M
HIPO icon
41
Hippo Holdings
HIPO
$859M
$5.52M 0.12%
110,868
– –
EM
42
DELISTED
Smart Share Global Ltd
EM
$5.26M 0.11%
4,080,000
– –
ROOT icon
43
Root
ROOT
$830M
$5.12M 0.11%
144,444
– –
ALGS icon
44
Aligos Therapeutics
ALGS
$31.2M
$5.08M 0.11%
94,603
– –
TUYA
45
Tuya Inc
TUYA
$1.09B
$5M 0.1%
1,689,359
– –
ZTO icon
46
ZTO Express
ZTO
$15.4B
$5M 0.1%
200,000
-56,453
-22% -$1.59M
FUTU icon
47
Futu Holdings
FUTU
$15.2B
$4.23M 0.09%
+130,000
New +$5.21M
DQ
48
Daqo New Energy
DQ
$762M
$4.13M 0.09%
+100,000
New +$4.2M
PRLD icon
49
Prelude Therapeutics
PRLD
$361M
$4.03M 0.08%
583,333
– –
SRZN icon
50
Surrozen
SRZN
$209M
$3.61M 0.08%
80,000
– –
1
2
3 4

Similar funds

ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AFA
AA Financial Advisors Columbus, Ohio $832M AUM 20.55% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $833M AUM 25.55% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $833M AUM 22.71% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $835M AUM 73.7% 1-Year Est. Return

HHLR Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, HHLR Advisors held 80 positions worth $4.79B, down 26% from $6.47B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

HHLR Advisors's Q1 2022 filing shows 4 new, 7 increased, 9 reduced and 16 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M. The largest sale was Legend Biotech, an estimated $192M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Technology.

  • HHLR Advisors's largest Q1 2022 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 36,834,320 shares worth $92.1M.
  • HHLR Advisors added most to DoorDash in Q1 2022, an estimated $280M increase.
  • HHLR Advisors's biggest Q1 2022 reduction was Legend Biotech, cutting an estimated $192M.
  • HHLR Advisors fully exited Erasca in Q1 2022, selling an estimated $73.6M.
  • HHLR Advisors's ten largest holdings make up 75% of its $4.79B portfolio in Q1 2022.
  • HHLR Advisors opened 4 new positions and closed 16 in Q1 2022.
  • HHLR Advisors's portfolio value fell 26% quarter-over-quarter to $4.79B.

Based on HHLR Advisors's 13F filing for Q1 2022, filed 16 May 2022.